MARKET

BNTX

BNTX

BIONTECH
NASDAQ
96.25
+0.25
+0.26%
After Hours: 97.09 +0.84 +0.87% 19:17 12/05 EST
OPEN
96.41
PREV CLOSE
96.00
HIGH
96.69
LOW
95.21
VOLUME
1.27M
TURNOVER
--
52 WEEK HIGH
129.27
52 WEEK LOW
81.20
MARKET CAP
23.14B
P/E (TTM)
-34.7711
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Nano-X Imaging (NNOX), Edgewise Therapeutics (EWTX) and BioNTech SE (BNTX)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Stryker (SYK)
TipRanks · 1d ago
Former FDA commissioners castigate plan to change vaccine approval standards
Seeking Alpha · 2d ago
Jefferies Sticks to Their Buy Rating for BioNTech SE (BNTX)
TipRanks · 2d ago
BioNTech Secures Majority Of CureVac Shares As Exchange Offer Advances
NASDAQ · 2d ago
The Bull Case For BioNTech (BNTX) Could Change Following Higher Guidance And Oncology Progress – Learn Why
Simply Wall St · 3d ago
Vaccine panel head who opposed COVID restrictions elevated to senior HHS role
Seeking Alpha · 3d ago
Vaccine committee considers changes to childhood schedule, NY Times reports
TipRanks · 3d ago
More
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Webull offers BioNTech SE - ADR stock information, including NASDAQ: BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.